|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable, net | |||||||||||||||||
| Unbilled contracts receivable, net | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Note receivable | |||||||||||||||||
| Deferred consideration from divestiture | |||||||||||||||||
| Assets held for sale | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Note receivable, noncurrent | |||||||||||||||||
| Deferred consideration from divestiture, noncurrent | |||||||||||||||||
| Unbilled contracts receivable, noncurrent | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Deferred tax assets | |||||||||||||||||
| Other noncurrent assets | |||||||||||||||||
| Assets held for sale, noncurrent | |||||||||||||||||
| Total assets | |||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||
| Current liabilities: | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued liabilities | |||||||||||||||||
| Deferred revenue | |||||||||||||||||
| Short-term debt | |||||||||||||||||
| Liabilities held for sale | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Long-term debt | |||||||||||||||||
| Deferred revenue, noncurrent | |||||||||||||||||
| Operating lease liabilities, noncurrent | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Other noncurrent liabilities | |||||||||||||||||
| Liabilities held for sale, noncurrent | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Stockholders' equity: | |||||||||||||||||
| Preferred stock: $0.001 par value; 6,000 shares authorized as of September 30, 2026 and December 31, 2025; no shares issued and outstanding as of September 30, 2026 and December 31, 2025 | |||||||||||||||||
| Common stock: $0.001 par value; 140,000 shares authorized as of September 30, 2026 and December 31, 2025; 48,789 and 46,925 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Total Company stockholders' equity | |||||||||||||||||
| Noncontrolling interest | |||||||||||||||||
| Total stockholders' equity | |||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...